Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Anti-FXa Concentration After Continuous Intravenous Infusion and Subcutaneous Dosing of Enoxaparin for Thromboprophylaxis in Critically Ill Patients

NCT02095509 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT02095509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02095509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Anti-FXa Concentration After Continuous Intravenous Infusion and Subcutaneous Dosing of Enoxaparin for Thromboprophylaxis in Critically Ill Patients
Lead sponsor
Tampere University Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
September 30, 2016
Enrollment
39 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism